<DOC>
	<DOC>NCT02568644</DOC>
	<brief_summary>The main objective of the study was to evaluate ginger efficacy as an adjuvant to ketoprofen for the treatment of headache and other symptoms related with migraine attacks.</brief_summary>
	<brief_title>Ginger Capsules for the Acute Treatment of Migraine Attacks</brief_title>
	<detailed_description>Patients with the diagnosis of migraine according to the IHS criteria were enrolled in the study during a migraine attack. Patients received two 200 mg capsules of dry ginger extract (5% active ingredient) or two capsules of placebo (cellulose) in addition to an intravenous dose of ketoprofen (100 mg) to treat the migraine attack.</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<criteria>Migraine diagnosis for at least one year; One to six migraine attacks per month. Patients with headaches not characterized as migraine; Pregnant or lactating women; Fertile and sexually active women who do not use contraception; Abuse of painkillers, alcohol or drugs; People with hypersensitivity to ginger; People with other neurological diseases; People in use of anticoagulant drugs; People who have started the disease after 50 years old.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Ginger</keyword>
	<keyword>Acute treatment</keyword>
</DOC>